Multisociety Clinical Practice Guidance for Safe Use of GLP-1 Receptor Agonists in Perioperative Period
Diabetologia 52 , 20462055 (2009)
Safety, side effects, and who should pause before starting All GLP-1 receptor agonists and the GIP/GLP-1 dual agonist tirzepatide share a well-characterized side-effect profile: nausea, vomiting, diarrhea, constipation, abdominal pain, and headache are common
Occasionally, surgery is considered for people who have suffered from gout over a long period of time to remove problematic tophi or to repair badly damaged joints
Sources include: Parker, C.H., Slattery, C., Brennan, D.J., & le Roux, C.W
On the pharmacy side, GLP-1s are placed in specialty tiers requiring high co-insurance or coinsurance